Roivant Sciences Ltd. · NASDAQ:ROIV
Sukhatme Mayukh reported 7 trades in Roivant Sciences Ltd. shares (Form 4)
Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026
From Nov 10 to Nov 12, 2026, Sukhatme Mayukh (Director, President & CIO) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.02 for US$6.79M, leaving 18,396,703 shares. Filed Nov 12, 2026 (Form 4).
- Shares
- 165,444 shares
- Price
- US$41.02 average (US$40.36 to US$42.01)
- Value
- US$6.79M
- Holding after
- 18,396,703 shares
- Trading plan
- No
- Role
- Director, President & CIO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Shares | Other | 26,152 | US$40.43 | 18,537,732 | Direct |
| Nov 10, 2026 | Common Shares | Other | 32,882 | US$41.13 | 18,504,850 | Direct |
| Nov 11, 2026 | Common Shares | Other | 32,672 | US$41.63 | 18,472,178 | Direct |
| Nov 11, 2026 | Common Shares | Other | 20,533 | US$42.01 | 18,451,645 | Direct |
| Nov 12, 2026 | Common Shares | Other | 44,723 | US$40.36 | 18,406,922 | Direct |
| Nov 12, 2026 | Common Shares | Other | 8,482 | US$41.13 | 18,398,440 | Direct |
| Nov 12, 2026 | Common Shares | Shares withheld for tax | 1,737 | US$41.85 | 18,396,703 | Direct |
Source
Download original · View original at SEC
Related
- Roivant Sciences Ltd.
- Sukhatme Mayukh
- Roivant Sciences Ltd. shareholders
- Form 4 · Sukhatme Mayukh · Oct 20, 2026
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Sukhatme Mayukh · Aug 21, 2026
- Form 4 · Sukhatme Mayukh · Aug 18, 2026
- Form 4 · Sukhatme Mayukh · Jul 2, 2026
- Form 4 · Gold Daniel Allen · Nov 18, 2026
- Form 4 · QVT Financial LP · Nov 18, 2026
- Form 4 · Manchester Keith S · Nov 18, 2026
- Form 4 · Gline Matthew · Nov 12, 2026
- Form 4 · Torti Frank · Nov 12, 2026